Counterfeit Cures: The Unseen Risks in India's Pharmaceutical Supply Chain Recent investigations into fake drug networks in Bengaluru, Delhi, and Rajasthan have exposed a critical vulnerability in India's healthcare system.
The alleged diversion of medicines from government hospitals to black market networks compromises patient safety and raises questions about the efficacy of existing regulatory measures.
In Bengaluru alone, 90 hospitals and clinics allegedly supplied with spurious or mislabelled medicines is a staggering number.